SCHEMBL6708940

SCHEMBL6708940

O=C(CCc1ccccc1)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.44
MAPK1 P28482 1/20 0.44
GRIK1 P39086 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TRPV1 Q8NER1 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
NCOR2 Q9Y618 1/20 0.39
PLCG2 P16885 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
NHERF1 O14745 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
ROCK2 O75116 1/20 0.37
HSPH1 Q92598 1/20 0.37
PYGL P06737 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710296 0.95 ADORA3 (0.41) ALOX15MAPK1GRIK1HDAC3HDAC1
SCHEMBL6707741 0.95 HDAC1 (0.40) ALOX15MAPK1GRIK1HDAC3HDAC1
SCHEMBL6709861 0.92 GRIK1 (0.41) MAPK1GRIK1SMN1; SMN2PLCG2MEN1
SCHEMBL6710377 0.91 MMP2 (0.42) GRIK1HDAC3HDAC1HDAC2NCOR2
SCHEMBL6712433 0.90 GRIK1 (0.42) MAPK1GRIK1SMN1; SMN2HDAC3HDAC1
SCHEMBL6708770 0.89 GRIK1 (0.41) GRIK1HDAC1PLCG2MEN1KMT2A
SCHEMBL6707994 0.88 CETP (0.43) GRIK1PLCG2NHERF1
SCHEMBL6713646 0.88 NHERF1 (0.40) GRIK1SMN1; SMN2PLCG2NHERF1KDM4E
SCHEMBL6711734 0.88 PARP14 (0.37) HDAC3HDAC1HDAC2NCOR2PLCG2
SCHEMBL6710141 0.88 GRIK1 (0.44) GRIK1PLCG2NHERF1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 ALOX15 857/4885MAPK1 2728/4885GRIK1 3885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.